Related Experiment Video
Updated: Jul 1, 2025

06:55
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
12.0K
Enabling large-scale screening of Barrett's esophagus using weakly supervised deep learning in histopathology
Kenza Bouzid1, Harshita Sharma1, Sarah Killcoyne2
1Microsoft Health Futures, Cambridge, UK.
Nature Communications
|March 12, 2024
Summary
A new deep learning method can detect Barrett's esophagus from H&E stained slides, improving early diagnosis. This AI approach aids pathologists, reducing workload and enhancing screening for this pre-malignant esophageal condition.
Area of Science:
- Oncology
- Pathology
- Artificial Intelligence
Background:
- Barrett's esophagus is a pre-malignant condition for esophageal adenocarcinoma.
- Current diagnostic methods like the Cytosponge-TFF3 test are resource-intensive.
- Large-scale screening is limited by the need for pathologist assessment of multiple slides and biomarkers.
Purpose of the Study:
- To develop a deep learning approach for detecting Barrett's esophagus using only H&E stained slides.
- To eliminate the need for expensive, localized expert annotations in the diagnostic workflow.
- To improve the capacity for large-scale screening of at-risk populations.
Main Methods:
- A deep learning model was trained using diagnostic labels from clinical trial data.
- The model was trained and validated on two independent datasets totaling 1866 patients.
- The approach utilizes routinely stained H&E slides, bypassing the need for TFF3 immunohistochemistry.
Main Results:
- The H&E deep learning model achieved an AUROC of 91.4% on the discovery dataset and 87.3% on the external test dataset.
- Performance was comparable to the TFF3 biomarker model.
- The semi-automated workflow reduced pathologist workload by 48% without compromising diagnostic accuracy.
Conclusions:
- Deep learning on H&E slides offers a viable, less resource-intensive method for Barrett's esophagus detection.
- This AI-driven approach can significantly enhance screening capacity and assist pathologists.
- The findings support the integration of AI into clinical workflows for improved patient outcomes in esophageal cancer prevention.
Related Concept Videos
Barrett Esophagus-I: Introduction
96
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
96
Barrett Esophagus-II: Clinical Manifestations and Management
150
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
150

